Phoenix Life Science

Hangzhou, China · Founded 2021 · Privately Held (backing)

Provider of life science research services and biotechnological research, intended for advancing molecular diagnostics and genetic analysis for clinical and pharmaceutical applications. Phoenix Life Science is based in Hangzhou, China and was founded in 2021.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—

Phoenix Life Science key facts

  • Provider of life science research services and biotechnological research, intended for advancing molecular diagnostics and genetic analysis for clinical and pharmaceutical applications.
  • Notable investors include S&G Investment.
  • Status: Privately Held (backing).

Who backs Phoenix Life Science

1
Free account
More of Phoenix Life Science with a free account
  • ·Watch Phoenix Life Science: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Phoenix Life Science funding rounds

No rounds on record

No funding rounds for Phoenix Life Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Phoenix Life Science investors

1 investor is on record for Phoenix Life Science, including S&G Investment.

About Phoenix Life Science

Provider of life science research services and biotechnological research, intended for advancing molecular diagnostics and genetic analysis for clinical and pharmaceutical applications. The company offers gene sequencing, molecular diagnostic kits, cell culture reagents, and laboratory testing services, thereby enabling them to accelerate clinical research, improve diagnostic accuracy, and enhance therapeutic innovation.

Sector
Healthcare
HQ
Hangzhou, China
Founded
2021
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation — not yet priced

Phoenix Life Science doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.